Cue Biopharma Inc. has laid off employees as it focuses resources on its autoimmune programs.
The Boston biotech said Thursday afternoon that it had reduced its staff by about 25%, impacting research, development and general and administrative roles. These cuts and the company’s other “operational efficiencies” are expected to extend its runway into mid-2025.
WATCH ANYTIME FOR FREE
 |
Stream NBC10 Boston news for free, 24/7, wherever you are. |
More on this story from Boston Business Journal
Get updates on what's happening in Boston to your inbox. Sign up for our News Headlines newsletter.
Copyright Boston Business Journal
